<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00229541</url>
  </required_header>
  <id_info>
    <org_study_id>FKZ 01GL0306</org_study_id>
    <nct_id>NCT00229541</nct_id>
  </id_info>
  <brief_title>Medical In-Patient Rehabilitation in Rheumatoid Arthritis</brief_title>
  <official_title>Medical In-Patient Rehabilitation in Rheumatoid Arthritis: Acceptance and Outcomes in Insurants of Compulsory Health Insurances and Statutory Pension Insurances (VERA)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Luebeck</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>AOK Schleswig-Holstein</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>BEK Nord</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Draeger and Hanse BKK</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>DAK Schleswig-Holstein</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>IKK Schleswig-Holstein</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>TK Schleswig-Holstein</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>LVA Schleswig-Holstein</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>BfA</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Deutsche Rheumaliga Schleswig-Holstein</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Berufsverband Deutscher Rheumatologen</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Luebeck</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The randomised controlled trial explores the efficacy of a counselling interview on an
      multidisciplinary multimodal intervention to ameliorate the somatic, mental and social
      medical progress of rheumatoid arthritis in gainfully employed insurants of compulsory health
      insurances and statutory pension insurances . Additionally, the feasibility to recruit a
      study population via databases of compulsory health insurances is examined.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Rheumatoid arthritis is the most prevalent inflammatory rheumatic disease. Limited
      participation of the individual patient accumulates with large amounts of indirect costs for
      society: About 40 % of the affected patients have to quit their jobs within the first three
      to four years after disease onset. Nevertheless, the German health care system still seems to
      lack an adequate supply, particularly in case of medical rehabilitation in early stages of
      disease. International clinical trials, reviews amd evidence-based guidelines emphasize the
      importance of an early multimodal multidisciplinary team care as in Germany provided by
      specialised clinics through three-week in-patient medical rehabilitation programs. The
      available study explores the efficacy of a counselling interview on an medical in-patient
      rehabilitation in a randomised controlled design. Exclusively, gainfully employed insurants
      of compulsory health insurances and statutory pension insurances are included in the study.

      Secondary, to avoid the problem of a selection bias caused by recruitment via clinics or
      doctors, the RCT tests the possibility to recruit potential participants by data of the
      co-operating health insurances on RA-specific diagnoses of work incapacity, hospital
      discharge diagnoses, and medical prescriptions within the past 24 months.

      Detailed process:

        1. Recruitment of a potential study population via health insurance data (defined search
           criteria: ICD-10 diagnoses M05/06/13/79 in case of work disability/hospital discharge,
           RA-specific medical prescriptions within the past 24 months)

        2. screening questionnaire to verify in-/exclusion criteria

        3. selection of eligible insurants (RA-criteria of American College of Rheumatology,
           clinical expert)

        4. baseline measurement (e.g. SF-36, RAQoL, FFbH-P, SPE)

        5. external stratified block by block randomization: intervention group (3- week medical
           in-patient rehabilitation) vs. control group (usual care)

        6. follow-up measurement (12 months after baseline)

        7. data transfer of health insurances and pension insurances

      Comparison:

      Looking at a 12-months follow-up, the intervention group (3-week medical in-patient
      rehabilitation) is expected to show significant enhancement in somatic, mental and social
      medical parameters concerning rheumatoid arthritis compared to a control group receiving
      usual care.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2003</start_date>
  <completion_date type="Actual">March 2006</completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>work incapacity (incidence, duration)</measure>
    <time_frame>baseline, 12 months follow-up</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>general health status (SF-36)</measure>
    <time_frame>baseline, 12 months follow-up</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Functional capacity (FFbH-P)</measure>
    <time_frame>baseline, 12 months follow-up</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life (RAQoL)</measure>
    <time_frame>baseline</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subjective prognosis of gainful employment (SPE-scale)</measure>
    <time_frame>baseline, 12 months follow-up</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Somatization (SCL-90-R)</measure>
    <time_frame>baseline, 12 months follow-up</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Depression</measure>
    <time_frame>baseline, 12 months follow-up</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">129</enrollment>
  <condition>Rheumatoid Arthritis</condition>
  <arm_group>
    <arm_group_label>IG</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>intervention group, receives counselling on medical inpatient rehabilitation by statutory health insurance, is intended to apply for a 3-wek medical inpatient rehabilitation at the co-operating clinic (Bad Bramstedt)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>KG</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>control group, receives usual care</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Counselling and 3-week medical in-patient rehabilitation</intervention_name>
    <description>Counselling and 3-week medical in-patient rehabilitation in IG</description>
    <arm_group_label>IG</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Rheumatoid arthritis / psoriatic arthritis (expert decision, ACR criteria)

          -  Insurant of co-operating health insurance and pension insurance

          -  Gainfully employed

          -  Eligible to receive a medical in-patient rehabilitation

        Exclusion Criteria:

          -  Polyarthritis, inflammatory intestinal diseases and diseases of connective tissue

          -  Currently work disabled

          -  Not able / not willing to co-operate

          -  Medical in-patient rehabilitation within past 48 months
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>62 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Heiner Raspe, Prof.Dr.Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Institute for Social Medicine, University of Luebeck</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Institute for Social Medicine, University of Luebeck</name>
      <address>
        <city>Luebeck</city>
        <zip>23538</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <link>
    <url>http://www.sozmed.uni-luebeck.de</url>
    <description>homepage Institute for Social Medicine, University of Luebeck</description>
  </link>
  <results_reference>
    <citation>Schlademann S, HÃ¼ppe A, Raspe H. [Results of a randomised controlled trial on the acceptance and the outcomes of a counselling on medical inpatient rehabilitation in gainfully employed members of statutory health insurances with rheumatoid arthritis (clinicaltrials.gov identifier NCT00229541)]. Gesundheitswesen. 2007 Jun;69(6):325-35. German.</citation>
    <PMID>17642037</PMID>
  </results_reference>
  <verification_date>October 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 27, 2005</study_first_submitted>
  <study_first_submitted_qc>September 27, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 29, 2005</study_first_posted>
  <last_update_submitted>October 26, 2007</last_update_submitted>
  <last_update_submitted_qc>October 26, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 29, 2007</last_update_posted>
  <keyword>Medical in-patient rehabilitation</keyword>
  <keyword>Gainfully employed</keyword>
  <keyword>Work incapacity</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arthritis</mesh_term>
    <mesh_term>Arthritis, Rheumatoid</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

